AMGN - Novo falls as long-time investor cuts stake on weight loss hype
2023-11-27 12:58:26 ET
More on Novo Nordisk
- Novo Nordisk: Plenty More Room To Run Despite Its Hefty Valuation
- Novo Nordisk: Massive Reality Check Awaits Greedy Investors
- Novo Nordisk: Healthy Gains Ahead, EPS Growth Seen, Technical Strength
- Lexaria stock rallies 20% on positive GLP-1 drug delivery study
- Novo's weight-loss drug Wegovy to make Asia debut
For further details see:
Novo falls as long-time investor cuts stake on weight loss hype